SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MEDX ... anybody following?
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
2240 62 0 MEDX
Emcee:  Ed Offstein Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1740Vanda Names New Board Member Tuesday June 5, 6:08 pm ET Vanda Names Howard H. PiIcebrg-6/6/2007
1739The efficacy and safety of ipilimumab (MDX-010) in patients with unresectable stIcebrg-6/6/2007
1738Kinetics of response to ipilimumab (MDX-010) in patients with stage III/IV melanIcebrg-6/6/2007
1737A phase II study of the anti-CTLA4 monoclonal antibody (mAb), CP-675,206, in patIcebrg-6/6/2007
1736Natural history of diarrhea associated with the anti-CTLA4 monoclonal antibody CIcebrg-6/6/2007
1735Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Icebrg-6/5/2007
1734Diatos and Medarex Announce Cancer Product Licensing Agreement PARIS and PRIcebrg-6/4/2007
1733Diatos Announces Positive Clinical Results for its DTS-201 Doxorubicin Prodrug PIcebrg-6/4/2007
1732Cell Genesys and Medarex Report Follow-Up Data From a Phase 1 Combination TherapIcebrg-6/4/2007
1731Clearance of monoclonal antibody (mAb) CP-675,206 by therapeutic plasma exchangeIcebrg-6/4/2007
1730Combination immunotherapy with GM-CSF and CTLA-4 blockade for hormone refractoryIcebrg-6/4/2007
1729OT: Greetings. Long time lurker, first time poster. Just like to express appreciDennis Long-6/3/2007
1728Celldex Therapeutics Announces Updated EGFRvIII Vaccine Data in Glioblastoma MulIcebrg-6/3/2007
1727Patients Who Took Investigational Melanoma Compound CP-675,206 Showed Favorable Icebrg-6/3/2007
1726Looks like PFE cp-675206 will have 5 items at ASCO. 4 in melanoma and 1 in CRC.kenhott-5/31/2007
1725Medarex Announces Collaborative Research Agreement with Mitsubishi Pharma ThursdIcebrg-5/31/2007
1724Celldex Therapeutics Announces Poster Presentations of Lead Product Candidates aIcebrg-5/31/2007
1723IDM Pharma initiated with "buy" Friday, May 25, 2007 6:04:59 AM ET CaIcebrg-5/28/2007
1722Near-term and future value catalysts [for the record - as reported at the recentIcebrg-5/26/2007
1721Interesting crossover design; I guess there was some undisclosed secondary endpotuck-5/26/2007
1720Investigative Crohn's Disease Drug Shows Efficacy, Especially in Infliximab Icebrg-5/26/2007
1719Phase I/II Study of an Anti-CD30 Monoclonal Antibody (MDX-060) in Hodgkin's Icebrg-5/25/2007
1718Celldex Therapeutics Initiates a Definitive Phase 2/3 Clinical Trial of CDX- 110Icebrg-5/24/2007
1717CTLA-4 blockade in murine bone marrow chimeras induces a host-derived antileukemIcebrg-5/23/2007
1716<I> Prediction: He's going to have trouble with the 20 minute IB presesoftware salesperson-5/19/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News